Healthcare stocks have come on strong since last August. What's more, low-quality, high-risk biotech names have helped support the global equity rally ever since the low last April. Cathie Wood’s ARK Genomic Revolution ETF ( ARKG ) has, not surprisingly, outperformed both theFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost ...